Safety Norms: Hematology and Oncology

1Purpose, Scope, and Safety Principles

These norms exist to prevent harm to patients, staff, and visitors during diagnosis, treatment, transfusion, supportive care, and follow-up for blood disorders and cancers. They apply to clinics, infusion areas, inpatient units, apheresis and transfusion areas, laboratories, pharmacies, and any home-based service in which a team member provides care.

The core principles are simple. Patient safety comes first. Treatment follows a signed order and an approved protocol. No one works outside their authorization. When a team member is uncertain, they stop the task, keep the patient safe, and escalate rather than guess.

• Must: every anticancer or transfusion activity follows a current, locally approved protocol or a documented individual order.
• Must: deviations from protocol are documented with the reason and the name of the approving clinician.
• Should: local leaders review these norms at least annually and whenever a major incident or regulatory change occurs.

2Roles, Competence, and Accountability

The prescribing clinician, such as a hematologist, oncologist, or qualified advanced practice provider, is responsible for the diagnosis, choice of regimen, dose justification, and informed consent discussion. A pharmacist verifies chemotherapy and high-alert medicines. Nurses and infusion staff administer treatment, assess the patient, and monitor for adverse effects. Laboratory and transfusion staff are accountable for specimen integrity and for issuing blood products. Schedulers, navigators, and support staff protect identity, records, and access.

Accountability means each person knows which tasks they are authorized to perform and who to call when a task falls outside that scope.

• Must: staff hold current credentials and documented competency sign-off for each task they perform, as required by local law and employer policy.
• Must: only staff with validated competency prepare, verify, or administer chemotherapy and biologic agents.
• Must: blood product issue and bedside verification are performed only by authorized staff using the local transfusion procedure.
• Must: staff do not start, change, or stop a treatment outside their authorization. They delegate to the prescriber or escalate.
• Should: each unit names a clinical lead and a pharmacy lead who are reachable during working hours.

3Course-Specific Hazards and Risk Assessment

Hematology and oncology work involves several activities with distinct hazards. Chemotherapy preparation and administration expose staff to hazardous drugs through skin contact, splashes, aerosols, and contaminated surfaces. Patients receiving treatment may develop extravasation if a vesicant leaks into surrounding tissue. Patients with low white cell counts, a condition called neutropenia, are at high risk of serious infection, and fever in this group can signal sepsis. Patients with low platelet counts face bleeding risks from procedures, falls, and some medicines. Transfusions carry risks of allergic, febrile, and hemolytic reactions, plus errors when the wrong product reaches the wrong patient. Tumor lysis syndrome, anaphylaxis to infusion drugs, spinal cord compression, and superior vena cava syndrome are time-critical emergencies.

Each hazard should be scored using a local matrix that combines likelihood and severity. A common approach rates risks as high, medium, or low. High-risk activities require documented controls and supervision before work begins. The assessment must be reviewed after any incident, change in drug or device, or change in service model.

• High: preparing or administering vesicant chemotherapy, high-alert medicines, transfusions, and central venous access care.
• High: procedures such as bone marrow aspiration or lumbar puncture, which require defined sedation, bleeding, and infection controls as set by local policy.
• Medium: handling hazardous waste, sharps, spill cleanup, and specimen transport.
• Medium: managing patients with fever and neutropenia outside the hospital setting.
• Low but reportable: minor needle sticks, small spills, and documentation discrepancies that do not reach the patient.

4Preventive Controls and Safe Work Practices

Informed consent must be obtained before chemotherapy, biologic therapy, transfusion, invasive procedures, and enrollment in clinical trials. The discussion covers the purpose, expected benefits, common and serious risks, alternatives, and the option to decline or withdraw. Interpreters are used when the patient needs them. Capacity is assessed and documented. Consent is recorded in the medical record, and the consent form is kept according to local policy. Where a patient lacks capacity, the locally recognized surrogate process applies, which varies by jurisdiction.

Patient identification uses at least two identifiers, such as full name and date of birth, checked against the wristband and order at every step: order entry, dispensing, preparation, bedside administration, and specimen collection. Chemotherapy doses are calculated from current height and weight using the protocol method, and the calculation is independently checked. Pre-treatment checks confirm laboratory values, allergies, performance status, and any protocol-specific tests before treatment begins. If a required value is missing or outside the protocol limit, treatment is held until the prescriber reviews it.

Infection prevention relies on hand hygiene before and after patient contact, aseptic technique for central line access and dressing changes, and avoidance of unnecessary invasive devices. Symptomatic staff do not work with severely immunocompromised patients without approval from occupational health. Visitors with symptoms of infection are asked to postpone visits. Each patient with fever or suspected neutropenia follows a written fever pathway that includes prompt clinician review and early antibiotic decisions according to local guidance.

• Must: two-identifier verification and wristband check before every chemotherapy, transfusion, and high-alert medicine.
• Must: independent double check for chemotherapy doses, blood product compatibility, and other high-alert medicines, as set by local policy.
• Must: hazardous drugs are prepared in a certified containment device and handled with protocol-specified personal protective equipment.
• Must: transfusions begin only after compatibility verification by two authorized staff at the bedside, with vital sign monitoring and a reaction plan in place.
• Must: stop the infusion and call the prescriber immediately for suspected extravasation, reaction, or unexplained deterioration.
• Should: bleeding precautions, fall prevention, and platelet thresholds are reviewed on each shift using the protocol.
• Should: staff vaccination and occupational health screening follow current national and local recommendations, which should be verified with the relevant authority.

5Equipment, Environment, Information, and Protective Safeguards

Personal protective equipment, or PPE, is selected according to the hazard assessment and the product information for the agent or device. For hazardous drugs, this typically includes gloves rated for chemotherapy, a protective gown, and eye and face protection when splashing is possible. Respiratory protection is used only when the local assessment requires it and staff have been fit tested and trained according to applicable rules. Improvised PPE is not permitted.

Equipment such as infusion pumps, refrigerators, biosafety cabinets, and blood storage units is maintained according to manufacturer instructions and local requirements. Temperature logs, cabinet certification records, and pump calibration records are kept current. Spill kits matching the agents in use are stocked and checked. Patients with severe neutropenia may need placement in rooms or areas that meet local infection control standards, such as higher air change rates or positive pressure rooms, where available.

• Must: spill kits, sharps containers, and hazardous waste bins are available where hazardous drugs are used, and staff know how to use them.
• Must: patient information is accessed only for care, through role-based electronic record permissions, and never shared in public areas, chat groups, or social media.
• Must: photographs of patients, medical records, or treatment areas are not taken on personal devices.
• Must: genetic, transfusion, and mental health information receives the same protection as other records, with any additional restrictions applied by local law.
• Should: disclosure of information to family or third parties follows documented consent and local privacy rules, which vary by jurisdiction and should be verified with the privacy officer.

6Incident Reporting, Emergency Response, and Escalation

All incidents, near misses, and unsafe conditions are reported within the same shift using the local incident system. A near miss is an event that could have caused harm but did not. Reporting is handled in a just culture, which means staff are supported when they report honestly and systems are examined before individuals are blamed. Patients and families are informed of harmful incidents according to local disclosure policy.

Emergencies require immediate action. For anaphylaxis, transfusion reaction, severe bleeding, sepsis, tumor lysis, or suspected spinal cord compression, staff stop the causative treatment when safe, maintain the airway and circulation, call the rapid response or emergency team, and notify the prescriber. Emergency services are contacted when the local plan requires it. A chemical spill or exposure is handled by removing the source, washing exposed skin with water, following the spill procedure, and reporting to occupational health. Staff do not attempt treatments beyond their authorization while waiting for a clinician.

• Must: each unit posts an emergency plan covering anaphylaxis, transfusion reaction, extravasation, hazardous drug exposure, and severe bleeding.
• Must: escalation to the prescriber is documented with the time, reason, and response.
• Must: a needle stick or splash to skin or eyes is reported immediately and treated according to the occupational exposure procedure.
• Should: a clinical escalation tool or early warning score is used to identify deteriorating patients, with thresholds set by local protocol.

7Records, Training, Inspection, and Review

Accurate records prove that safe steps were taken. Required records include orders, verification logs, consent forms, pre-treatment laboratory results, chemotherapy preparation records, transfusion records, equipment logs, spill reports, and competency files. Retention periods depend on local law and professional rules and should be verified with the records office.

Training is delivered before a task is performed independently and refreshed according to policy. Training covers hazardous drug handling, transfusion safety, infection prevention, emergency response, privacy, and the use of the electronic record. Inspections check storage, equipment certification, PPE supplies, cleaning, and labeling. Quarterly audits review verification compliance, near miss trends, and documentation quality, and findings lead to named actions with deadlines.

• Must: competency sign-off is recorded before independent practice and repeated at the interval set by policy.
• Must: biosafety cabinets and other containment equipment are inspected and certified as required by the manufacturer and local rules.
• Should: audit results and trends are reviewed by a multidisciplinary safety group, which includes nursing, pharmacy, medicine, laboratory, and patient representatives where possible.
• Should: protocols are reviewed against current evidence and guidelines on a fixed schedule, with changes communicated to all staff before use.

8Limits of This Guidance and Verification

These norms are a framework, not a substitute for local approved procedures, product labeling, or professional judgment. Clinical protocols, medication doses, and infection control measures must come from current evidence, national and local guidance, and the approved formulary. Laws governing consent, privacy, controlled medicines, hazardous waste, and occupational exposure vary by jurisdiction. Verify the current applicable versions with competent authorities, regulators, or qualified professionals before relying on any requirement described here.

Staff who are unsure whether a task is within their authorization should stop and ask the responsible clinician. Asking is always the safe choice in this field.

Implementation checklist

• Confirm two identifiers and wristband match before any chemotherapy, transfusion, or high-alert medicine.
• Verify consent is documented, current, and specific to the planned treatment before starting.
• Confirm an independent double check is complete for chemotherapy doses and blood product compatibility.
• Check pre-treatment laboratory values and protocol criteria, and hold treatment if a required value is missing.
• Use the correct PPE, containment device, and spill kit for every hazardous drug task.
• Monitor transfusions and infusions with a reaction plan ready and stop immediately for suspected reactions.
• Apply hand hygiene, aseptic technique, and the fever pathway for neutropenic patients.
• Report every incident and near miss within the shift and escalate deterioration to the prescriber.
• Access patient records only for care and never share identifiable information outside authorized channels.
• Verify laws, standards, and manufacturer instructions with competent authorities or qualified professionals.